Kasurinen, Aaro, et al. “Tumor-Associated Trypsin Inhibitor (TATI) and Tumor-Associated Trypsin-2 (TAT-2) Predict Outcomes in Gastric Cancer”. Acta Oncologica, vol. 59, no. 6, June 2020, pp. 681-8, doi:10.1080/0284186X.2020.1733655.